Identifying Undiagnosed HFpEF Among Patients With Type 2 Diabetes Using Ultromics AI HFpEF Algorithm
Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
A pragmatic electronic health record (EHR) based randomized controlled trial to evaluate the utility of providing Ultromics EchoGo analysis results and recommendations for HF risk prevention therapies using an EHR embedded clinical decision support tool.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients with diagnosis of Type 2 diabetes and High WATCH DM score.
• Echocardiogram available in last 6-months.
Locations
United States
Texas
UT Southwestern Medical Center
RECRUITING
Dallas
Contact Information
Primary
Ambarish Pandey, MD
Ambarish.Pandey@UTSouthwestern.edu
617-869-8957
Time Frame
Start Date: 2025-08-06
Estimated Completion Date: 2027-06-15
Participants
Target number of participants: 800
Treatments
Experimental: EHR Alert Group
Provider will receive a computer-based alert notifying them that the patient has subclinical HFpEF as determined by the Ultromics EchoGo algorithm and associated guideline recommendations for the management of these patients. The alert will include guideline-based and standard-of-care recommendations for the use of SGLT-2 inhibitors and/or GLP-1 RA (if obesity is present). The purpose of the alert is to inform the providers about the risk of heart failure and provide them guidance regarding the guideline-recommended standard of care. The providers can choose to provide care as deemed fit based on the information provided
Active_comparator: Standard Message Group
We will provide a standard message to the provider detailing guideline-recommended medications for type 2 diabetes. This will not contain information about the Ultromics EchoGo algorithm. The providers can choose to provide care as deemed fit based on the information provided
Related Therapeutic Areas
Sponsors
Leads: University of Texas Southwestern Medical Center